Some studies have shown that TINCR is HER-2-specific lncRNA, which is significantly upregulated in breast cancer, knocking down TINCR can inhibit the proliferation of breast cancer cells, promote cell apoptosis, and inhibit the process of cell cycle in vitro2. Here, TINCR is linked to breast cancer.